Logo image of GFN

General Finance Corp (GFN) Stock Fundamental Analysis

NASDAQ:GFN - Nasdaq -

19.01  +0.02 (+0.11%)

Fundamental Rating

2

Taking everything into account, GFN scores 2 out of 10 in our fundamental rating. GFN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of GFN have multiple concerns. GFN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

GFN had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 3.13%
ROE 12.11%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 12.23%
PM (TTM) 7.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

There is no outstanding debt for GFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that GFN is in the distress zone and has some risk of bankruptcy.
GFN has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

GFN has a Current Ratio of 1.33. This is a normal value and indicates that GFN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 0.88 indicates that GFN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.88

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 307.14% over the past year.
GFN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.88% yearly.
The Revenue has decreased by -6.03% in the past year.
GFN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.25% yearly.
EPS 1Y (TTM)307.14%
EPS 3Y229.14%
EPS 5Y32.88%
EPS Q2Q%203.13%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y8.78%
Revenue growth 5Y3.25%
Sales Q2Q%0.04%

3.2 Future

Based on estimates for the next years, GFN will show a very strong growth in Earnings Per Share. The EPS will grow by 46.79% on average per year.
Based on estimates for the next years, GFN will show a decrease in Revenue. The Revenue will decrease by -0.25% on average per year.
EPS Next Y1%
EPS Next 2Y5.98%
EPS Next 3Y31.47%
EPS Next 5Y46.79%
Revenue Next Year-2.95%
Revenue Next 2Y0.07%
Revenue Next 3Y-0.39%
Revenue Next 5Y-0.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GFN Yearly Revenue VS EstimatesGFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GFN Yearly EPS VS EstimatesGFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.68, GFN is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 26.70, GFN is valued a bit cheaper.
GFN is valuated quite expensively with a Price/Forward Earnings ratio of 29.18.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.49, GFN is valued a bit more expensive.
Industry RankSector Rank
PE 16.68
Fwd PE 29.18
GFN Price Earnings VS Forward Price EarningsGFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.79
GFN Per share dataGFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GFN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as GFN's earnings are expected to grow with 31.47% in the coming years.
PEG (NY)16.68
PEG (5Y)0.51
EPS Next 2Y5.98%
EPS Next 3Y31.47%

0

5. Dividend

5.1 Amount

GFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

General Finance Corp

NASDAQ:GFN (5/25/2021, 8:00:00 PM)

19.01

+0.02 (+0.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners15.53%
Ins Owner Change0%
Market Cap574.88M
Analysts60
Price Target19.38 (1.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP14.84%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.68
Fwd PE 29.18
P/S 1.66
P/FCF N/A
P/OCF N/A
P/B 2.82
P/tB N/A
EV/EBITDA 9.79
EPS(TTM)1.14
EY6%
EPS(NY)0.65
Fwd EY3.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.44
BVpS6.75
TBVpSN/A
PEG (NY)16.68
PEG (5Y)0.51
Profitability
Industry RankSector Rank
ROA 3.13%
ROE 12.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.23%
PM (TTM) 7.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.88
Altman-Z 1.09
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)307.14%
EPS 3Y229.14%
EPS 5Y32.88%
EPS Q2Q%203.13%
EPS Next Y1%
EPS Next 2Y5.98%
EPS Next 3Y31.47%
EPS Next 5Y46.79%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y8.78%
Revenue growth 5Y3.25%
Sales Q2Q%0.04%
Revenue Next Year-2.95%
Revenue Next 2Y0.07%
Revenue Next 3Y-0.39%
Revenue Next 5Y-0.25%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A